1. Dhar K, Jena KK, Mehto S, Sahu R, Murmu KC, Mahajan AA, Behera S, Putchala RK, Mathew RJ, Bal R, Kundu S, Das SK, Chauhan S, Satapathy S, Yadav R, Priyadarsini S, Padala KR, Namdigalla P, Mishra S, Muralidhara P, Bansal K, Sannula K, Prasad P, Bokara KK, Sowpati DT, Ghosh-Roy A, Mahapatra PK, Khadilkar RJ, Yelagandula R, Chauhan S (2025). Programmed cell revival from imminent cell death enhances tissue repair and regeneration. EMBO Journal

2. Dwivedi P, Barage S, Singh R, Jha A, Choudhury S, Agrawal A, Rangarajan V (2025). PET-based radiomic analysis in multicentre lung cancer study and impact of feature domain harmonization. Physical and Engineering Sciences in Medicine.

3. Asija S, Bhat S, Chatterjee A, Chekuri G, Purwar R, Goda JS (2025). Mass spectrometry-based proteomics in glioblastoma – current understanding and future impact. Brain Research.

4. Nagaraju P, Ojha S, Saha S (2025). Exploring the influence of donor physiognomic factors on packed red cell unit quality: A retrospective analysis from a tertiary care transfusion center. Asian Journal of Transfusion Science. 19(1):36-41.

5. Prabhash K, Noronha V, Patil V, Menon N, Shah M, Singh A, Pande N, Goud S, More S, Sharma R, Yadav A, Nakti D, Panda G, Saha S, Pawar A, Shetake A, Shah S, Nawale K, Sharma S, Banavali S, Goel N, Badwe R (2025). A randomized trial of patient navigation with symptom-monitoring in advanced lung cancer. European Journal of Cancer.

6. Budkh A, Bagal S, Gupta D, Mhamane S, Singh R, Qayyumi B Sinha AR, Singh SK, Pradhan S, Chaturvedi P, Badwe R, Gupta S (2025) Cancer burden, its pattern and survival in Muzaffarpur: Findings from first population-based cancer registry of Bihar state, India. ecancer. 19:1972.

7. National Cancer Registry Programme Investigator Group; Mathur P, Sathishkumar K, Das P, Santhappan S...Gupta S, Budukh A, Thejaswini B... Vijay CR, Mathew A...Dikshit R...Sharma A, Ahmed Z, Chaturvedi P...etal (2025). Cancer Incidence and Mortality Across 43 Cancer Registries in India. JAMA Network Open. 8(8):e2527805.

8. Gadewal N, Karn V, Talati V, Bastikar V (2025).Gene regulatory network and multi-omics analysis reveals key genetic drivers in clear cell renal cell carcinoma. Network Modeling Analysis in Health Informatics and Bioinformatics. 14: 93.

Thesis
1. Debashmita Sarkar. 2025. To decipher the role of histone acetyltransferase GCN5 in DNA Double Strand Break Repair.( LIFE09201804012) (Guide: Dr. Manoj Mahimkar)

The XDeathDB visualization platform provides a comprehensive cell death and their crosstalk resource for deciphering the signaling network organization of interactions among different cell death modes associated with many cancer types

Furtwängler B, Üresin N, Richter S, Schuster MB, Barmpouri D, Holze H, Wenzel A, Grønbæk K, Theilgaard-Mönch K, Theis FJ, Schoof EM, Porse BT (2025). Mapping early human blood cell differentiation using single-cell proteomics and transcriptomics. Science.

In 2013, FDA approved trusted source ado-trastuzumab emtansine (T-DM1) to treat HER2-positive breast cancer.

2025 Advanced Centre for Treatment, Research and Education in Cancer (ACTREC)